blood-brain barrier

New York, New York, September 23, 2026 Apertura Gene Therapy announced that it will provide Lexeo Therapeutics with access...

Waltham, Massachusetts, July 28, 2026 Dyne Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has cleared...

Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...

HYOGO, Japan, July 21, 2026 JCR Pharmaceuticals announced that the United Arab Emirates (UAE) has granted marketing authorization for...

LEXINGTON, Mass., July 13, 2026 Voyager Therapeutics presented new six-month good laboratory practice (GLP) toxicology data demonstrating that its...

NEW YORK | July 9, 2026 Apertura Gene Therapy, a biotechnology company developing next-generation adeno-associated virus (AAV) capsids for...

CAMBRIDGE, Massachusetts, July 1, 2026 Nona Biosciences has entered into a strategic collaboration with Lonza to develop a next-generation...

BALTIMORE, June 29, 2026 CraniUS Therapeutics has received an initial $1.1 million award through the National Institutes of Health...

SOUTH SAN FRANCISCO, Calif., June 18, 2026 Denali Therapeutics Inc. announced it has entered into a definitive agreement to...

HONG KONG, June 18, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), has announced...